Evidence map›Paper›PMID 19250553›Full record

ArticleBMC developmental biology2009

The conserved WW-domain binding sites in Dystroglycan C-terminus are essential but partially redundant for Dystroglycan function.

A S Yatsenko, M M Kucherenko, M Pantoja, K A Fischer, J Madeoy, W-M Deng, M Schneider, S Baumgartner, J Akey, H R Shcherbata and 1 more

Open access · hybridAbstract read
In one paragraph

Article in BMC developmental biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Dystroglycan versatility in cell adhesion: a tale of multiple motifs.Cell communication and signaling : CCS · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 5 countries.

A S YatsenkoDepartment of Biochemistry, Institute for Stem Cell and Regenerative Medicine, Program in Neurobiology and Behaviour, University of Washington, Seattle, WA 98195, USA. anubius81@gmail.com
M M Kucherenko
M Pantoja
K A Fischer
J Madeoy
W-M Deng
M Schneider
S Baumgartner
J Akey
H R Shcherbata
H Ruohola-Baker
University of Washington · USSeattle University · USFlorida State University · USLund University · SEMax Planck Society · DEUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDystroglycan (Dg) is a transmembrane protein that is a part of the Dystrophin Glycoprotein Complex (DGC) which connects the extracellular matrix to the actin cytoskeleton. The C-terminal end of Dg contains a number of putative SH3, SH2 and WW domain binding sites. The most C-terminal PPXY motif has been established as a binding site for Dystrophin (Dys) WW-domain. However, our previous studies indicate that both Dystroglycan PPXY motives, WWbsI and WWbsII can bind Dystrophin protein in vitro.

resultsWe now find that both WW binding sites are important for maintaining full Dg function in the establishment of oocyte polarity in Drosophila. If either WW binding site is mutated, the Dg protein can still be active. However, simultaneous mutations in both WW binding sites abolish the Dg activities in both overexpression and loss-of-function oocyte polarity assays in vivo. Additionally, sequence comparisons of WW binding sites in 12 species of Drosophila, as well as in humans, reveal a high level of conservation. This preservation throughout evolution supports the idea that both WW binding sites are functionally required.

conclusionBased on the obtained results we propose that the presence of the two WW binding sites in Dystroglycan secures the essential interaction between Dg and Dys and might further provide additional regulation for the cytoskeletal interactions of this complex.

Indexed as

Amino Acid SequenceAnimalsAnimals, Genetically ModifiedBinding SitesCell PolarityConserved SequenceCytoskeletonDrosophilaDrosophila melanogasterDrosophila ProteinsDystroglycansDystrophinHumansMolecular Sequence DataMutationOocytesDrosophila ProteinsDystroglycansDystrophin

Identifiers

PMID19250553
PMCPMC2660313
OpenAlexW2118137506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.